Blijlevens et al developed the daily gut score (DGS) for monitoring clinical signs of gastrointestinal toxicity associated with cancer therapy. This can be used to monitor the patient following initiation of therapy. The authors are from the University Medical Centre St. Radboud Nijmegen and University Hospital Maastricht in The Netherlands.